Showing results (201-210 of 625) with videos related to

Sort By:
Pageof 63
Journal of Clinical Hypertension (Greenwich, Conn.)|June 17, 2018
Fifteen years of LIFE (Losartan Intervention for Endpoint Reduction in Hypertension)-Lessons learned for losartan: An "old dog playing good tricks"Niki Katsiki, Konstantinos Tsioufis, Dilek Ural, et al.
Clinical Cardiology|March 28, 2007
Left bundle-branch block--pathophysiology, prognosis, and clinical managementPietro Francia, Cristina Balla, Francesco Paneni, et al.
Vascular Health and Risk Management|August 21, 2007
Multivariate risk assessment and risk score cards in hypertensionGiuliano Tocci, Valentina Valenti, Sebastiamo Sciarretta, et al.
Clinical Drug Investigation|December 11, 2008
Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre studyMassimo Volpe, Peter Brommer, Uwe Haag, et al.
Expert Review of Cardiovascular Therapy|July 4, 2007
Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertensionGiuliano Tocci, Sebastiano Sciarretta, Caterina Facciolo, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|January 4, 2019
Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should KnowMassimo Volpe, Giovanna Gallo, Allegra Battistoni, et al.
European Journal of Preventive Cardiology|October 26, 2019
Antihypertensive drugs and the risks of cancer: More fakes than factsAllegra Battistoni, Giuliano Tocci, Vivianne Presta, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|February 11, 2005
Hypertension and heart failure: role of neurohormonal mechanismsMassimo Volpe, E Pagannone, G Tocci, et al.
Future Cardiology|October 7, 2009
Use of predictive markers to improve cardiovascular protectionGiuliano Tocci, Francesco Paneni, Beatrice Ponziani, et al.
Expert Opinion on Pharmacotherapy|November 23, 2012
Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapyGiuliano Tocci, Francesco Paneni, Jasmine Passerini, et al.
Pageof 63